Loading
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Dec 2025 for Immix Biopharma, Inc., €107k.
Filing timeline
BuySaleGabriel S. Morris
Insider track record
Disclosed buys
8
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+82.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Gabriel S. Morris: trading record in brief
Gabriel S. Morris (finance chief) discloses dealings in Immix Biopharma, Inc. to SEC (Form 4). In total, 15 filings cover trades dated from 20 December 2021 to 10 December 2025.
No open-market sale appears; the market trades are 8 purchases worth €46k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 share grants. In 2025 alone, the filings show 3 purchases and no sales.
A typical purchase (the median) is worth €4,798. 8 out of 8 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 10 December 2025 came the latest disclosure, an open-market purchase for €4,357 in Immix Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gabriel S. Morris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
156,000 shares@ US$0.8054.6% of flowCommon StockSEC:0001493152-25-027107:0
2,600 shares@ US$1.974.8% of flowCommon StockSEC:0001493152-25-013918:0
Canonical exit: 15 Dec 2025 (T+90)
2,225 shares@ US$2.2795.2% of flowCommon StockSEC:0001641172-25-015755:0
Canonical exit: 16 Sept 2025 (T+90)
2,500 shares@ US$2.11923.6% of flowCommon StockSEC:0001493152-24-023288:0
Canonical exit: 5 Sept 2024 (T+90)
3,300 shares@ US$1.80994.0% of flowCommon StockSEC:0001493152-24-022654:0
Canonical exit: 2 Sept 2024 (T+90)
194,218 sharesCommon StockSEC:0001493152-24-020776:0
4,500 shares@ US$2.23156.8% of flowCommon StockSEC:0001493152-24-019368:0
Canonical exit: 12 Aug 2024 (T+90)
5,200 shares@ US$0.943.5% of flowCommon StockSEC:0001493152-22-032555:0
Canonical exit: 12 Feb 2023 (T+90)
74,116 shares@ US$0.8528.5% of flowCommon StockSEC:0001493152-21-032035:0
9 of 9 declarations
